Tekla Healthcare Investor... (HQH)
Tekla Healthcare Investors Statistics
Share Statistics
Tekla Healthcare Investors has - shares outstanding. The number of shares has increased by 0% in one year.
| Shares Outstanding | n/a |
| Shares Change (YoY) | 0% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 23.27% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 69 |
| FTD / Avg. Volume | 0.03% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is 4.52 and the forward PE ratio is null. Tekla Healthcare Investors's PEG ratio is 0.02.
| PE Ratio | 4.52 |
| Forward PE | n/a |
| PS Ratio | 77.69 |
| Forward PS | n/a |
| PB Ratio | 0.79 |
| P/FCF Ratio | 0 |
| PEG Ratio | 0.02 |
Enterprise Valuation
Tekla Healthcare Investors has an Enterprise Value (EV) of 836.68M.
| EV / Sales | 77.69 |
| EV / EBITDA | 0 |
| EV / EBIT | 0 |
| EV / FCF | 0 |
Financial Position
The company has a current ratio of 0.43, with a Debt / Equity ratio of 0.
| Current Ratio | 0.43 |
| Quick Ratio | 0.43 |
| Debt / Equity | 0 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is 17.45% and Return on Invested Capital is -0.02%.
| Return on Equity | 17.45% |
| Return on Assets | 17.43% |
| Return on Invested Capital | -0.02% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | undefined |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -2.78% in the last 52 weeks. The beta is 0.79, so Tekla Healthcare Investors's price volatility has been higher than the market average.
| Beta | 0.79 |
| 52-Week Price Change | -2.78% |
| 50-Day Moving Average | 16.22 |
| 200-Day Moving Average | 17.6 |
| Relative Strength Index (RSI) | 54.81 |
| Average Volume (20 Days) | 199,404 |
Income Statement
In the last 12 months, Tekla Healthcare Investors had revenue of 10.77M and earned 184.95M in profits. Earnings per share was 3.55.
| Revenue | 10.77M |
| Gross Profit | 10.77M |
| Operating Income | -220.27K |
| Net Income | 184.95M |
| EBITDA | n/a |
| EBIT | -220.27K |
| Earnings Per Share (EPS) | 3.55 |
Balance Sheet
The company has 56 in cash and 0 in debt, giving a net cash position of 56.
| Cash & Cash Equivalents | 56 |
| Total Debt | n/a |
| Net Cash | n/a |
| Retained Earnings | 117.95M |
| Total Assets | 1.06B |
| Working Capital | -791.22K |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | 0 |
Margins
Gross margin is 100%, with operating and profit margins of -2.05% and 1717.36%.
| Gross Margin | 100% |
| Operating Margin | -2.05% |
| Pretax Margin | 1717.36% |
| Profit Margin | 1717.36% |
| EBITDA Margin | n/a |
| EBIT Margin | -2.05% |
| FCF Margin | n/a |
Dividends & Yields
HQH pays an annual dividend of $2.85, which amounts to a dividend yield of 13.44%.
| Dividend Per Share | $2.85 |
| Dividend Yield | 13.44% |
| Dividend Growth (YoY) | 18.75% |
| Payout Ratio | 80.74% |
| Earnings Yield | 22.1% |
| FCF Yield | 0% |
Analyst Forecast
Currently there are no analyst rating for HQH.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | 372.2 |
| Piotroski F-Score | 3 |